Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03161756 |
Title | Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma (CHARLI) |
Acronym | CHARLI |
Recruitment | Unknown status |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Melanoma and Skin Cancer Trials Limited |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Border Medical Oncology Research Unit | Albury | New South Wales | 2640 | Australia | Details | |
Bendigo Health | Bendigo | New South Wales | 3550 | Australia | Details | |
Calvary Mater Newcastle | Waratah | New South Wales | 2298 | Australia | Details | |
Royal Brisbane and Women's Hospital | Herston | Queensland | 4029 | Australia | Details | |
Royal Hobart Hospital | Hobart | Tasmania | 7000 | Australia | Details | |
Box Hill Hospital | Box Hill | Victoria | 3128 | Australia | Details | |
Austin Health | Heidelberg | Victoria | 3084 | Australia | Details | |
Peter MacCallum Cancer Centre | Melbourne | Victoria | 3000 | Australia | Details | |
Alfred Health | Melbourne | Victoria | 3004 | Australia | Details | |
Sir Charles Gairdner Hospital | Nedlands | Western Australia | 6009 | Australia | Details |